News
03-01-2013, 10:50 PM
A groundbreaking new study led by the University of Kentucky Markey Cancer Center's Dr. Peter Zhou found that triple-negative breast cancer cells are missing a key enzyme that other cancer cells contain - providing insight into potential therapeutic targets to treat the aggressive cancer.
More... (http://www.news-medical.net/news/20130302/Study-shows-triple-negative-breast-cancer-cells-missing-key-enzyme.aspx)
More... (http://www.news-medical.net/news/20130302/Study-shows-triple-negative-breast-cancer-cells-missing-key-enzyme.aspx)